Central Carolina Community College alumni working in the biotechnology industry took center stage at a recent biotechnology networking event held at the Dennis A. Wicker Civic & Conference Center in ...
Zacks Investment Research on MSN
Is Invesco Biotechnology & Genome ETF (PBE) a strong ETF right now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund launched on 06/23/2005. What Are ...
Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...
Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino? The honest answer is that it can be either.
"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...
Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...
4don MSN
PDS Biotechnology stock crashes, strategic refocus pivots to metastatic colorectal cancer program
<?xml encoding="utf-8" ?> PDS Biotechnology Corporation PDSB shares have fallen by about 67% on Tuesday as the company announced a strategic refocus on its PDS0301 program for metastatic colorectal ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date - Dose-dependent anti-tumo ...
Operator: Hello and welcome to Vir Biotechnology's Second Quarter 2026 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded. [Operator Instructions] I ...
IASO Biotechnology ('IASO Bio) today announced the completion of its acquisition of MediSix Therapeutics ('MediSix'), a Singapore-based immune cell engineering and cell therapy company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results